Dr Dolan wrote to United Kingdom Haemophilia Centres Doctors' Organisation colleagues informing them of the intended de-notification of patients only exposed to UK fractionated blood products during 1980-1989. Read more about Dr Dolan wrote to United Kingdom Haemophilia Centres Doctors' Organisation colleagues informing them of the intended de-notification of patients only exposed to UK fractionated blood products during 1980-1989.
The Chief Medical Officer (England), on behalf of the CMOs of all four nations, set up the CJD Incidents Panel which was asked to develop a framework for the management of possible exposures to CJD through medical procedures which would then be subject to consultation with interested bodies and organisations. Read more about The Chief Medical Officer (England), on behalf of the CMOs of all four nations, set up the CJD Incidents Panel which was asked to develop a framework for the management of possible exposures to CJD through medical procedures which would then be subject to consultation with interested bodies and organisations.
Within two years of the announcement that there was a probable link between BSE and vCJD, an inquiry was set up to "establish and review the history of the emergence and identification of BSE and new variant CJD in the United Kingdom". Read more about Within two years of the announcement that there was a probable link between BSE and vCJD, an inquiry was set up to "establish and review the history of the emergence and identification of BSE and new variant CJD in the United Kingdom".
In the First Annual Report of the Spongiform Encephalopathy Advisory Committee, SEAC considered the results of two studies in "Nature" and became convinced that the evidence of the link between BSE and vCJD had become "compelling". Read more about In the First Annual Report of the Spongiform Encephalopathy Advisory Committee, SEAC considered the results of two studies in "Nature" and became convinced that the evidence of the link between BSE and vCJD had become "compelling".
"Haemophilia" carried an article titled "Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia". Read more about "Haemophilia" carried an article titled "Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia".
The CJD Incidents Panel's framework for the management of possible exposures to CJD through medical procedures drew particularly on the document "Det Norske Veritas Risk Assessment of Exposure to vCJD Infectivity in Blood and Blood Products for Department of Health". Read more about The CJD Incidents Panel's framework for the management of possible exposures to CJD through medical procedures drew particularly on the document "Det Norske Veritas Risk Assessment of Exposure to vCJD Infectivity in Blood and Blood Products for Department of Health".
A letter from Dr Sinka of the Health Protection Agency to Dr Dolan stated that "individuals who only received plasma products between 1980 and 1989 should now have their treatment history re-assessed to confirm this fact and if it is confirmed, they should be de-notified" of being at an increased risk of vCJD. Read more about A letter from Dr Sinka of the Health Protection Agency to Dr Dolan stated that "individuals who only received plasma products between 1980 and 1989 should now have their treatment history re-assessed to confirm this fact and if it is confirmed, they should be de-notified" of being at an increased risk of vCJD.
The BSE Inquiry Report Volume 1 Findings and Conclusions reported that: "The impression thus given to the public that BSE was not transmissible to humans was a significant factor leading to the public feeling of betrayal when it was announced on 20 March 1996 that BSE was likely to have been transmitted to people." Read more about The BSE Inquiry Report Volume 1 Findings and Conclusions reported that: "The impression thus given to the public that BSE was not transmissible to humans was a significant factor leading to the public feeling of betrayal when it was announced on 20 March 1996 that BSE was likely to have been transmitted to people."
SEAC reported that the evidence favoured a conclusion that there was a link between BSE and vCJD, but this was not (yet) sufficient to be regarded as scientific proof of a causative link. Read more about SEAC reported that the evidence favoured a conclusion that there was a link between BSE and vCJD, but this was not (yet) sufficient to be regarded as scientific proof of a causative link.
In a letter from Dr Winyard of the NHS Executive to NHS Trust medical directors, he stated: "There may clearly be some circumstances where clinicians will decide to inform a particular patient of the reason for the product withdrawal...In such circumstances it is for the clinician to decide how best to respond". Read more about In a letter from Dr Winyard of the NHS Executive to NHS Trust medical directors, he stated: "There may clearly be some circumstances where clinicians will decide to inform a particular patient of the reason for the product withdrawal...In such circumstances it is for the clinician to decide how best to respond".